From #ESCMID2025 - Interleukin-6 shows promise as a biomarker to diagnose #sepsis early in high-risk patient groups such as neonates, children, and pregnant women.
Full story 👉 buff.ly/RQwK5v9
#IDMed #PediatricMed
Preliminary results of the Candida IV study at #ISHAM2025 and #ESCMID2025
Study is still open to join 🔬🥼👩🔬
From #ESCMID2025 - Interleukin-6 shows promise as a biomarker to diagnose #sepsis early in high-risk patient groups such as neonates, children, and pregnant women.
Full story 👉 buff.ly/r9Ik0Qo
#IL6
From #ESCMID2025 - The first-in-class antibacterial #gepotidacin is noninferior to the standard first-line option in people with uncomplicated urogenital #gonorrhea.
Full story 👉 buff.ly/dEWuVrB
#MedNews
Für Purple Mountain Pictures (USA) produzierte Drehstrom Film im Auftrag von Cepheid Video-Content bei ESCMID 2025 in Wien – Fokus: Infektionskrankheiten & AMR.
🎥 Jetzt ansehen: www.youtube.com/watch?v=Y7gq...
Weitere Infos auf www.drehstrom.at
#ESCMID2025 #AMR #Videoproduktion
#TeachID #idsky really enjoyed listening to this podcast episode #ESCMID2025 late breaker abstracts podcasts.apple.com/us/podcast/c... thank you! @cmicomms.bsky.social
Infectiologie
Retrouver l’actualité du congrès européen d'Infectiologie #ESCMID2025 sur notre page dédiée : études phares sur la Prep, les données en vie réelle de la vaccination contre les infections respiratoires, le métapneumovirus, et plus encore
http://ms.spr.ly/63320Snv3i
#Métapneumovirus : plus de complications cardiaques qu’avec la grippe
Résultats de l'étude FLUVAC, présentée au congrès #ECCMID2025, avec les Drs Paul Loubet et Benjamin Davido
#ESCMIDGlobal2025 #ESCMID2025
http://ms.spr.ly/63324SnJky
Quelles sont les données en vie réelle de la #vaccination contre les infections respiratoires (VRS, pneumocoque, COVID) ?
Résultats présentés au congrès #ECCMID2025, avec les Drs Paul Loubet et Benjamin Davido
#ESCMIDGlobal2025 #ESCMID2025
http://ms.spr.ly/63322SRL96
ICYMI: Two-part video interview with Novavax Vice President, Matthew Rousculp, about the SHIELD study presented at #ESCMID2025. #IDsky #MEDsky
Pt. 1: "Fewer Side Effects, Less Missed Work"
Pt. 2: "Informed Decisions & Vaccine Hesitancy"
Watch both interviews here: www.contagionlive.com/videos
📢 La Fundació, present a l’#ESCMIDGlobal2025 a Viena:
🔹 En Javier Diez va presentar dos pòsters sobre enterobacteris multiresistents en ecosistemes aquàtics i aortitis pneumocòccica.
🔹 La Laura Soldevila va exposar un cas clínic de dengue.
#Recerca #SalutGlobal #ESCMID2025
Art meets science at #ESCMID2025
Love these. 🙏🏽
Love the graphic!! How very 2025.
#ESCMID2025
The age of augmented intelligence in medicine is here.
#ESCMID2025
We need to make this the norm. All in science need to engage more here on BlueSky.
That cesspool of 𝕏 is no place for anything more than political propaganda, disinformation and porn bots.
#ESCMID2025
if only I could spell. #ESCMID2025
Some of my favorite art pieces from #ESCMID2025.
A prevailing theme throughout the lectures was the effect Climate change is having on Infectious Diseases.
Last week at #ESCMID2025, OHT’s Divija Samria presented two of our key OHT collaborative studies on the #gender dynamics of antibiotic use & #AMR. Both studies highlight the urgent need for gender-responsive #AMRpolicy.
Learn about OHT’s work on gender & AMR: onehealthtrust.org/research-are...
#ESCMID2025 : CPE brought the voice of cancer patients to the fight against #AMR.
CPE urged action on:
🔹 Rising infection-related mortality
🔹 Treatment delays from drug resistance
🔹 The urgent need for patient-centred AMR strategies
🔗 More on AMR: lnkd.in/en9J9fUS
ℹ️ Full article: lnkd.in/dQ9SnX79
Congrats to Prof Karin Thursky from our Infectious Diseases team for a brilliant keynote on the future of antimicrobial stewardship at #ESCMID2025 in Vienna!
Her key message was that it needs to be reframed away from antimicrobial resistance & focus on patient quality & safety.
Study published in EurekAlert showed that over 3 million children died from AMR-related infections in 2022, with Southeast Asia and Africa accounting for 1.4 million of those deaths. #ESCMID2025 #IDsky #MEDsky
Read more: www.contagionlive.com/view/over-3-...
Final conversations of the day at Stand E83 as #ESCMIDGlobal winds down.
It’s been a great week of shared ideas, new connections, and exciting possibilities in diagnostics.
Missed us? Let's connect via: zurl.co/b0MQG
#GADx #ESCMID2025 #Diagnostics #LateralFlow
Slightly underwhelmed and offended, AMR in Asia - yes Asia is "a" hotbed, but others parts, other areas are all equally "responsible"
Best part of the talk "cats of ESCMID -2025"
#amr #antimicrobial_resistance #cats #catsofinternet #escmid #escmid2025 #escmidglobal #catsofescmid
At #ESCMID2025, Louise Cremer presented new data on the immunogenicity of COVID-19 vaccination in immunocompromised patients – an important step toward protecting vulnerable groups. #DZIF #InfectionResearch #BonnCologne
Louise Cremer präsentierte auf der #ESCMID2025 neue Daten zur Immunogenität der COVID-19-Impfung bei immungeschwächten Patienten – ein wichtiger Beitrag zum Schutz vulnerabler Gruppen. #DZIF #Infektionsforschung #BonnKöln
Wir freuen uns, dass Louise Cremer vom DZIF-Standort BonnKöln ihre Forschung zur COVID-19-Impfung bei immungeschwächten Patient:innen auf der #ESCMID2025 in Wien präsentiert – unterstützt durch ein DZIF-Reisestipendium! #DZIF #InfectionResearch #ESCMID2025 @dzif.bsky.social
Candida diagnostics in endovascular infections. Is @brukercorporation.bsky.social #MALDI better for Candida pararugosa? #ESCMID2025
